May 14 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 576 mln 781 mln
(-26.2 pct) (+3.0 pct)
Operating loss 595 mln loss 173 mln
Recurring loss 678 mln loss 155 mln
Net
Net loss 668 mln loss 167 mln
EPS loss 76.00 yen loss 19.82 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T